Recap: Theravance Biopharma Q4 Earnings
Recap: Theravance Biopharma Q4 Earnings
Theravance Biopharma (NASDAQ:TBPH) reported its Q4 earnings results on Monday, February 26, 2024 at 04:05 PM.
Theravance Biopharma（納斯達克股票代碼：TBPH）於2024年2月26日星期一下午4點05分公佈了其第四季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
Theravance Biopharma missed estimated earnings by -13.0%, reporting an EPS of $-0.17 versus an estimate of $-0.15.
Theravance Biopharma報告的每股收益爲-0.17美元，未達到預期的-13.0％，而預期的收益爲-0.15美元。
Revenue was up $2.92 million from the same period last year.
收入比去年同期增長了292萬美元。
Past Earnings Performance
過去的收益表現
Last quarter the company beat on EPS by $0.04 which was followed by a 5.0% increase in the share price the next day.
上個季度，該公司的每股收益高出0.04美元，隨後第二天股價上漲了5.0％。
Here's a look at Theravance Biopharma's past performance:
以下是Theravance Biopharma過去的表現：
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.21 | -0.16 | -0.26 | -0.17 |
| EPS Actual | -0.17 | -0.13 | -0.24 | -0.21 |
| Revenue Estimate | 15.00M | 15.24M | 13.84M | 15.73M |
| Revenue Actual | 15.69M | 13.75M | 10.42M | 14.65M |
| 季度 | 2023 年第三季度 | 2023 年第二季度 | 2023年第一季度 | 2022 年第四季度 |
|---|---|---|---|---|
| 每股收益估算 | -0.21 | -0.16 | -0.26 | -0.17 |
| 實際每股收益 | -0.17 | -0.13 | -0.24 | -0.21 |
| 收入估算 | 15.00M | 15.24 億 | 13.84 億 | 15.73 億 |
| 實際收入 | 15.69 億 | 13.75 億 | 10.42 億 | 14.65 億 |
To track all earnings releases for Theravance Biopharma visit their earnings calendar here.
要追蹤Theravance Biopharma發佈的所有業績，請在此處訪問他們的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成，並由編輯審閱。